an hour agoCOVIDD-19: “Modernnaggins more effective than Pfizer”
Periskopi(5 years ago)
(5 years ago)All my vaccines. RNA is effective and offer considerable protection, but Moderna is more effective than Pfizer / BioNTech, according to a comparison about their effectiveness. The comparison was based on an analysis of the electronic medical data of nearly 450,000 people who were vaccinated with both vaccines. According to the study, Moderna vaccine lands with [...]
According to the study, Moderna vaccine lowers 21% the risk of infection and 41% the risk of hospitalization compared to Pfizer/ BioNTech.
Both vaccines are effective. But no matter which kind of alfa prevailed initially and then Delta, Modern was slightly more effective, said Juan Kazas, an associate professor at Harvard Medical School and the Brigham & Women's Hospital in Boston.
Efficiency was compared to five indicators: cases with Ovid-19, symptoms, hospitalizations, ICU stays, and deads by Ovid 19.
The comparison was initially made at 219,842 US Army veterans who were vaccinated with Pfizer between January and May 2021 and as many others as were vaccinated with Modernna. In the next 24 weeks after the vaccine (at a time when the alpha version was widespread), the risk of coronary infection was estimated in 4,52 cases of 1,000 people vaccinated with Modernna versus 5.75 per 1,000 with Pfizer, reports abcnews. al
And compared with Moderna vaccinated, vaccinators with Pfizer have developed more symptoms (0.44 per 1000), hospitalization (0.55/1000), ICU (0.10/10/10) and death (0.02 / 1000).
The lowest risk behind the Moderna vaccine was confirmed for a longer period of time (July 2021), when the Delta version was already widespread. In this comparison, the risk of being diagnosed with Covid-19 over the 12 weeks after the vaccine was 6.54 cases of 1,000 per se with Pfizer compared to Modernna.
In view of the high efficiency of Moderna and Pfizer vaccines, it is recommended that we all be vaccinated with one of the” vaccines, Dickerman said.
But, however, a further assessment of the efficiency and safety of two m vaccines is needed RNA.
